CD4+ Tumor-infiltrating Lymphocytes in Neoadjuvant Chemotherapy-treated Invasive Breast Cancer of No Special Type
Background: Neoadjuvant chemotherapy (NAC) is an integral component of modern treatment for invasive breast cancer with no special type (IBC-NST). The interaction between the immune system and cancer, particularly through immune-infiltrating lymphocytes (TIL), continues to be studied to understand h...
Saved in:
Main Authors: | Primariadewi Rustamadji (Author), Elvan Wiyarta (Author), Meike Pramono (Author), Sinta Chaira Maulanisa (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential of AKT2 expression as a predictor of lymph-node metastasis in invasive breast carcinoma of no special type
by: Primariadewi Rustamadji, et al.
Published: (2021) -
Association of Src with Nottingham prognostic index in breast cancer: Implications for breast cancer prognostication
by: Primariadewi Rustamadji, et al.
Published: (2024) -
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
by: Yun Liang, et al.
Published: (2018) -
High Infiltration of CD68+/CD163− Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma
by: Maria C. Svensson, et al.
Published: (2022) -
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
by: M. Liontos, et al.
Published: (2021)